{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-028921","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.558986+00:00","generated_at":"2026-05-16T12:22:39.784312+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oncotelic launches PDAOAI platform and opens TGF-β corpus access","bullets":["Launched PDAOAI, an evidence-interrogation platform for extracting biological signals from large datasets without training custom LLMs.","Providing open access to a TGF-β literature corpus of over 125,000 PubMed abstracts via a dedicated Discord research channel.","Platform aims to enable researchers to analyze complex biomedical data without proprietary data training."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-028921","json":"https://secwatch.observer/filing/0001493152-25-028921.json","markdown":"https://secwatch.observer/filing/0001493152-25-028921.md","text":"https://secwatch.observer/filing/0001493152-25-028921.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/0001493152-25-028921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:22:39.784312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}